Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Melanoma × Biological Products × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Refractory/Relapse Neuroblastoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Nasopharyngeal Carcinoma 1 Melanoma 1 Hysterectomies for Low- or Intermediate-risk Endometrial Carcinoma 1

Interventions

pembrolizumab 54 Nivolumab 52 Ipilimumab 29 Cyclophosphamide 15 binimetinib 10 Specimen Handling 10 Magnetic Resonance Spectroscopy 10 fludarabine 9 Radiosurgery 9 Opdualag 9 encorafenib 8 Interleukin-2 8 Biopsy 8 relatlimab 7 aldesleukin 7 Blood Specimen Collection 7 atezolizumab 6 Immunotherapy 6 cemiplimab 5 Paclitaxel 5 CTLA-4 Antigen 5 Bevacizumab 5 trametinib 4 lifileucel 4 dabrafenib 4 Temozolomide 4 spartalizumab 3 fludarabine phosphate 3 Surgical Procedures, Operative 3 Standard of Care 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02828202 2025-02-11

MelBase

Assistance Publique - Hôpitaux de Paris

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡